At the end of the latest market close, Altimmune Inc. (ALT) was valued at $12.60. In that particular session, Stock kicked-off at the price of $12.98 while reaching the peak value of $13.3639 and lowest value recorded on the day was $12.55. The stock current value is $13.13.Recently in News on September 14, 2022, Altimmune Announces Significant Reductions in Liver Fat Content and Body Weight in 12-Week Phase 1b Clinical Trial of Pemvidutide in Subjects with NAFLD. All 3 pemvidutide dosing groups (1.2 mg, 1.8 mg, 2.4 mg) achieved the primary endpoint of relative and absolute reductions in liver fat, with a 68.5% relative reduction in liver fat content in subjects receiving 1.8 mg dose at 12 weeks of treatment. You can read further details here
Altimmune Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $23.49 on 09/02/22, with the lowest value was $3.83 for the same time period, recorded on 05/12/22.
Altimmune Inc. (ALT) full year performance was -13.52%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Altimmune Inc. shares are logging -44.10% during the 52-week period from high price, and 242.82% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.83 and $23.49.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 817780 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Altimmune Inc. (ALT) recorded performance in the market was 37.55%, having the revenues showcasing 35.19% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 650.29M, as it employees total of 47 workers.
Specialists analysis on Altimmune Inc. (ALT)
During the last month, 0 analysts gave the Altimmune Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 11.38, with a change in the price was noted +8.44. In a similar fashion, Altimmune Inc. posted a movement of +183.88% for the period of last 100 days, recording 2,125,966 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Altimmune Inc. (ALT)
Raw Stochastic average of Altimmune Inc. in the period of last 50 days is set at 21.59%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 15.17%. In the last 20 days, the company’s Stochastic %K was 13.44% and its Stochastic %D was recorded 16.20%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 37.55%. Additionally, trading for the stock in the period of the last six months notably improved by 84.21%, alongside a downfall of -13.52% for the period of the last 12 months. The shares increased approximately by -38.17% in the 7-day charts and went down by -26.57% in the period of the last 30 days. Common stock shares were driven by 35.19% during last recorded quarter.